These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7948450)

  • 1. Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression.
    Orlikov AB; Prakhye IB; Ryzov IV
    Biol Psychiatry; 1994 Jul; 36(2):97-102. PubMed ID: 7948450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma kynurenine levels and the dexamethasone test in patients with endogenous anxiety disorders and depression].
    Orlikov AB; Prakh'e IB; Ryzhov IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):83-5. PubMed ID: 1963008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
    Carroll BJ; Feinberg M; Greden JF; Haskett RF; James NM; Steiner M; Tarika J
    J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stress in interpreting the dexamethasone suppression test.
    Blouin J; Spindler E; Perez E; Blouin A; Hotz S; Hakkaku J
    Can J Psychiatry; 1992 Dec; 37(10):724-7. PubMed ID: 1473078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary testosterone levels and major depressive illness in men.
    Davies RH; Harris B; Thomas DR; Cook N; Read G; Riad-Fahmy D
    Br J Psychiatry; 1992 Nov; 161():629-32. PubMed ID: 1422612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1080-5. PubMed ID: 6497570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression, anxiety and the dexamethasone suppression test in hospitalized prepubertal children.
    Livingston R; Martin-Cannici C
    Hillside J Clin Psychiatry; 1987; 9(1):55-63. PubMed ID: 3653843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months.
    Widmer J; Bovier P; Karege F; Raffin Y; Hilleret H; Gaillard JM; Tissot R
    Neuropsychobiology; 1992; 26(4):173-9. PubMed ID: 1299790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S; Beckmann H
    Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of the dexamethasone suppression test in endogenous depressive patients.
    Lu RB; Ho SL; Huang HC; Lin YT
    Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.